AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Feb 18, 2025
33003_dirs_2025-02-18_26cec729-99d5-4d8c-8555-35082a813839.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-02-13
Reporting Person: Brooks Gabriel (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-13 | Common Stock | M | 10937 | — | Acquired | 26068 | Direct |
| 2025-02-14 | Common Stock | S | 3256 | $3.96 | Disposed | 22812 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | Restricted Stock Units | $ | M | 10937 | Disposed | Common Stock (10937) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
F2: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
F3: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.